Methods of cancer treatment with IGF1R inhibitors

Details for Australian Patent Application No. 2007334456 (hide)

Owner SCHERING CORPORATION

Inventors Yao, Siu-Long; Wang, Yan; Zong, Chen; Wang, Yaolin; Ladha, Mohamed H.; Lu, Brian Der-Hua; Seidel-Dugan, Cynthia

Agent Griffith Hack

Pub. Number AU-A-2007334456

PCT Pub. Number WO2008/076278

Priority 60/870,937 20.12.06 US; 60/946,011 25.06.07 US; 60/979,274 11.10.07 US; 60/874,589 13.12.06 US

Filing date 11 December 2007

Wipo publication date 26 June 2008

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

9 July 2009 PCT application entered the National Phase

  PCT publication WO2008/076278 Priority application(s): WO2008/076278

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp. Amendments

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007334468-Optimized non-canonical zinc finger proteins

2007334451-Method for replicating influenza virus in culture